Sign in
CompletedNo phase

TMS for Anxiety and Trauma-related Disorders

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
15 people enrolled
Started
19 Jun 2024
Ended
13 Apr 2025
Type of study
Interventional
Treatments tested
  • transcranial magnetic stimulation
Record updated
24 June 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Diagnosis of generalized anxiety disorder (GAD), social anxiety disorder (SAD), panic disorder (PD), and/or post-traumatic stress disorder (PTSD) as defined by DSM-5 criteria
  • Male or female between 18 and 60 years old
  • Right-handed
  • Can understand and sign an informed consent document
  • Beck Anxiety Inventory (BAI) score of 16 or higher
  • On a stable medication/psychotherapy regimen for at least 6 weeks prior to baseline visit and throughout the duration of the study
  • In good general health, as ascertained by medical history
  • Pharmacological treatment resistance or psychotherapeutic treatment resistance

Who cannot take part

  • Substance use disorders, eating disorders, significant suicidal ideation, mental disorder due to a medical or neurocognitive condition, lifetime psychosis, bipolar disorder, developmental disorders
  • History of brain surgery and epilepsy
  • Presence of metallic foreign bodies, such as cardiac pacemakers and stents
  • Any medical condition or medication that increases the risk of seizures
  • Current severe somatic disease, such as cancer, heart failure, pneumonia, etc
  • Pregnancy
  • Intellectual disability
  • Severe claustrophobia that prevents the use of MRI

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The present pilot study will apply accelerated intermittent theta burst stimulation (aiTBS) to a novel transcranial magnetic stimulation (TMS) target for anxiety derived via causal network mapping.

The group in the trial

  • Open-label aiTBS to novel right dmPFC TMS anxiety targetTreatment being tested

    Treatment: transcranial magnetic stimulation

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Accelerated Intermittent Theta Burst Stimulation to a Novel DLPFC Target for Anxiety and Trauma-related Disorders: a Pilot Study
Record updated
24 June 2026